Stroke prevention following modified endoscopic ablation and appendectomy for atrial fibrillation

被引:0
作者
Nan Ma
Zhaolei Jiang
Fei Chen
Hang Yin
Fangbao Ding
Ju Mei
机构
[1] Shanghai Jiaotong University,Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medicine
来源
Heart and Vessels | 2016年 / 31卷
关键词
Atrial fibrillation; Stroke; Surgery; Ablation;
D O I
暂无
中图分类号
学科分类号
摘要
We reported the results of stroke prevention following modified endoscopic procedure for atrial fibrillation. 82 patients underwent modified endoscopic procedure for atrial fibrillation (AF), in whom 47 had paroxysmal, 28 had persistent, and 7 had long-standing atrial fibrillation. CHA2DS2VASC median score was 3 (range from 0 to 8). The procedure was performed on the beating heart, through 3 ports on the left chest wall. Pulmonary vein isolation and ablation of the left atrium were achieved by bipolar radiofrequency ablation. Left atrial appendage (LAA) was excluded by stapler. Brain CT, cardiac CT and 24-h Holter monitoring were performed following the procedure. The procedure was successfully completed for all patients. The mean duration was 122 ± 40.1 min. LAA was excluded after appendectomy and checked by intraoperative transesophageal echocardiography. The mean follow-up duration was 24.3 ± 3.5 months. No patients showed signs and symptoms of transient ischemic attack or stroke. No new positive findings were demonstrated by recurring brain CT scan performed after the procedure. Cardiac CT confirmed the absence of LAA and thrombosis in the left atrium. 87.8 % (72/82) of all patients were in sinus rhythm. Our results demonstrate that the modified endoscopic procedure is a safe, effective, and appropriate treatment for AF, which restores sinus rhythm and may be associated with the prevention of AF-related stroke.
引用
收藏
页码:1529 / 1536
页数:7
相关论文
共 190 条
[11]  
Schotten U(2013)An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation Europace 15 652-662
[12]  
Savelieva I(2009)Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies Mayo Clin Proc 84 643-1953
[13]  
Ernst S(1994)Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 154 1945-977
[14]  
Van Gelder IC(2011)Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients Thromb Haemost 106 968-592s
[15]  
Al-Attar N(2008)Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 546s-1419
[16]  
Hindricks G(2007)Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action Arch Intern Med 167 1414-2389
[17]  
Prendergast B(1997)Warfarin use among patients with atrial fibrillation Stroke 28 2382-131
[18]  
Heidbuchel H(2014)Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial Eur J Cardiothorac Surg 45 126-988
[19]  
Alfieri O(1991)Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 983-1740
[20]  
Angelini A(2004)Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry Eur Heart J 25 1734-638